Adrenergic, beta-1-, Receptor (ADRB1) (C-Term) Peptide
Quick Overview for Adrenergic, beta-1-, Receptor (ADRB1) (C-Term) Peptide (ABIN8094269)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- ADRB1 Peptide - C-terminal region
-
Sequence
- SDDDDDDVVG ATPPARLLEP WAGCNGGAAA DSDSSLDEPC RPGFASESKV
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-ADRB1 Antibody (ARP30421_T100),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- ADRB1 (Adrenergic, beta-1-, Receptor (ADRB1))
-
Background
-
Background Information: ADRB1 is a beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. It mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling.
Alternative Symbols: ADRB1R, B1AR, BETA1AR, RHR
-
Molecular Weight
- 52kDa
-
Gene ID
- 153
-
NCBI Accession
- NP_000675
-
UniProt
- P08588
Target
-